TITLE

Pneumatosis intestinalis in association with acute sickle cell crisis

AUTHOR(S)
Sultan, Aqib; Shah, Dhiren; Bhargava, Nikhil; Roy, Hemant K
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS195
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Pneumatosis Intestinalis in Association with Acute Sickle Cell Crisis" by Aqib Sultan, Dhiren Shah, Nikhil Bhargava, and Hermant K. Roy is presented.
ACCESSION #
66954919

 

Related Articles

  • Mystery of the Crooked Cell. DeRosa, Donald A.; Wolfe, B. Leslie // American Biology Teacher;Feb99, Vol. 61 Issue 2, p137 

    Provides information on a laboratory school activity about sickle-cell anemia. Symptoms of an irregularly shaped blood cells; Materials; Instructions on how to organize a role play, to demonstrate the theory behind electrophoresis.

  • Age Influences Prevalence of Malb in Childhood Sickle Cell Disease.  // Kidney;Mar/Apr99, Vol. 8 Issue 2, p66 

    Determines the prevalence of microalbuminuria (Malb) in children with homozygous sickle cell disease (HbSS), and to determine factors associated with increased prevalence. Prvalence of Malb in the age group 10-18 years; Prevalence of Malb in adults by the second decade of life.

  • New hope for children with sickle cell disease. Segal, M. // FDA Consumer;Mar1989, Vol. 23 Issue 2, p14 

    Reports on new treatments for sickle cell anemia, a disease which primarily affects black children. Eight percent of black Americans carry a gene for sickle hemoglobin and one in every 400 black newborns in the US has sickle cell anemia or a related disease; Symptoms; Special problems in...

  • The genetics of sickle cell anemia.  // FDA Consumer;Mar1989, Vol. 23 Issue 2, p18 

    Detailed explanation of the genetic traits of sickle cell anemia.

  • Sickle cell treatment shows promise of cure.  // Jet;5/7/90, Vol. 78 Issue 4, p33 

    Discusses a drug, hydroxyurea, which is showing potential as a treatment for sickle cell anemia.

  • Sickle cell anemia: Drug lowers painful crises by 50%, benefits 9% of patients.  // Modern Medicine;Mar95, Vol. 63 Issue 3, p12 

    Reports on the reduction of the frequency of painful episodes and hospitalization in sickle cell anemia patients by hydroxyurea in a study sponsored by the National Heart, Lung, and Blood Institute in Bethesda, Maryland. Dosage; Percentage reduction of painful crises; Action of hydroxyurea.

  • Hammer and sickle. Portyansky, Elena // Drug Topics;4/6/98, Vol. 142 Issue 7, p16 

    Reports that hydroxyurea, an antineoplastic agent revamped under the brand-name Droxia, has been approved for the treatment of adult patients with sickle cell anemia. Details on sickle cell anemia; Manufacturers of hydroxyurea; Information from Samuel Charache, M.D.; Hydroxyurea's effect on...

  • Sickle-cell treatment hailed.  // Consumer Reports on Health;Apr95, Vol. 7 Issue 4, p40 

    Reports that researchers have found that hydroxyurea can help prevent the debilitating painful attacks caused by sickle-cell anemia.

  • Literature reviews. Roth, Karl S.; Lampe, John B. // Clinical Pediatrics;Oct1995, Vol. 34 Issue 10, p568 

    Comments on the paper entitled `Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle-Cell Anemia,' by S. Charache, M.L. Terrin et al published in N. Engl. J. Med. Stimulation by cytostatic agent hydroxyurea of synthesis of fetal hemoglobin (HbF); Gene manipulation that is...

  • New hope for kids with blood disorder.  // Current Science;3/30/90, Vol. 75 Issue 15, p8 

    Describes sickle-cell anemia, a blood disease that causes joint swelling, heart damage, and bouts of severe pain. Focuses on research of the drug called hydroxyurea and its anti-sickling possibilities. Research involving replacement of sickle-cell genes.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics